Discover the benefits of cold exposure therapy, potential risks, and practical guidelines for safely incorporating this practice into your wellness routine.

Barzolvolimab is the first drug to demonstrate clinical benefit in patients with chronic inducible urticaria in a large, randomized, placebo-controlled study. Up to 53.1% of patients with cold ...

Please provide your email address to receive an email when new articles are posted on . The impact of CSU on quality of life, sleep and work impairment differed based on disease severity. Full ...

Jasper expects to report data around mid-year 2025 from 4 cohorts: the 240mg single dose cohort (4 additional patients), 240mg Q8W cohort (8 patients), 240mg followed by 180mg Q8W cohort (8 patients), ...

Allergies and infections are common causes, but urticaria can also be triggered by cold, heat, pressure, vibration, stress, and even water. The location, timing, and look of the rash can provide clues ...

Urticaria affects 10% to 25% of the population at some point in their life (Henderson, Fleischer, & Feldman, 2000). It is characterized by short-lived swellings of the skin, mouth, and genitalia ...

The Best Cold Medicines Aren't in the Cough and Cold Aisle Most OTC cold medicines don't work. Here are the things that actually will help—and where to find them.

“There are definitely individuals who can have something called cold-induced urticaria. This is a situation where patients are exposed to lower temperatures, and they can actually break out in hives ...